| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2082882 | Drug Discovery Today: Therapeutic Strategies | 2011 | 7 Pages |
Abstract
Successful repositioning of a drug product depends on carefully considering and integrating both intellectual property and regulatory exclusivities. Patent strategies directed to protecting new formulations, indications and methods of use, when combined with strategically repositioned products, can provide effective and long lasting product exclusivity even where the underlying API, and the original formulations, indications and methods of use are off-patent.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
Richard B. Smith,